Neurofeedback training significantly increased positive valence ratings for negative stimuli and enhanced frontal oxygenated hemoglobin levels in patients with schizophrenia compared to treatment as usual.
RCT (n=25)
Randomly assigned
No
Does neurofeedback training improve emotional behavior regulation and frontal neural activity in patients with schizophrenia?
Neurofeedback training may improve emotion regulation and increase frontal neural activity in patients with schizophrenia.
p-value: p=<0.05
Recent neuroscience research tried to identify biological markers underlying schizophrenia’s (SZ) symptoms. Results showed a functional hypofrontality in SZ patients during both cognitive and emotional tasks. Here, we submitted an experimental (E) group of patients to a neurofeedback (NF) training during emotion induction (T1) and assessed its efficacy by comparing the frontal neural activity before (T0) and after it (T2), with regard to a control (C) group. Functional near-infrared spectroscopy (fNIRS) was used during an emotional task with valence and arousal rating. Behavioral results showed that patients of both groups could identify pictures’ valence, both in T0 and T2. However, a significant interaction effect revealed that negative and positive stimuli received more positive values in T2 compared to T0 only in E group, as a consequence of an alleged more functional management of negative feelings. Such results were paralleled by imaging data that showed increased O2Hb levels over frontal areas for positive and negative pictures compared to neutral ones, which were even more evident in the E group in T2. The preliminary results of the present study highlight the possible application of NF training to sustain patients’ achieving more awareness and regulation during emotion processing.
Balconi et al. (Wed,) conducted a rct in Schizophrenia (n=25). Neurofeedback training vs. Treatment-As-Usual (TAU) was evaluated on Valence ratings for negative pictures at 5 weeks (T2) (p=<0.05). Neurofeedback training significantly increased positive valence ratings for negative stimuli and enhanced frontal oxygenated hemoglobin levels in patients with schizophrenia compared to treatment as usual.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: